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Infection with the protozoan parasitePlasmodium falciparum
results in the severest form of human malaria. The symptoms and
pathology of malaria occur during the intra-erythrocytic stage
of the parasite life-cycle, and virulence has been shown to be
associated with parasite multiplication and the selectivity of ery-
throcyte invasion [1]. Understanding the parasite molecules that
mediate erythrocyte selectivity may lead to new interventions
aimed at limiting virulence.
Invasion of erythrocytes byP. falciparummerozoites involves
multiple ligand–receptor interactions, known as invasion path-
ways [2]. Several alternate erythrocyte surface receptors have
been identified, including the major glycoproteins A and B, as
well as the unrelated glycophorin C. Others have been described
by their sensitivity to enzymes such as neuraminidase, chy-
motrypsin and trypsin, but the specific erythrocyte proteins
involved are not known. Laboratory strains of P. falciparum
vary in their dependence on these alternate receptors for
invasion.
Recognition of alternate receptors on the erythrocyte sur-
face by P. falciparum merozoites is thought to be mediated
by members of the reticulocyte-binding homolog (PfRh) and
erythrocyte binding antigen (PfEBA) ligand families; each fam-
ily contains five paralogous proteins [2]. Importantly, distinct
laboratory lines express different members of the PfRh family
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[3–8]. This variant expression could explain the use of alter-
native invasion pathways by different parasite lines. Minimal
quantitative variation has been noted in the expression of PfEBA
paralogs, and all appear to be expressed in most laboratory lines
[9,10].
Antibody inhibition studies and genetic studies have yielded
a wealth of information implicating members of the PfRh and
PfEBA families in the invasion process in vitro [6,9–11]. The
ability to knockout various parasite ligands implies a degree
of redundancy among the alternative ligands. Strikingly, some
knockouts lead to a shift in dependence on other ligands—an
observation found to be dependent on the parasite genetic back-
ground.
Our current understanding of alternative erythrocyte invasion
patterns relies on either laboratory adapted strains that have been
passaged for many generations or on wild isolates that have been
recently adapted to in vitro culture. Since selection pressures
for efficient growth in vitro may differ from those in vivo, first-
round invasion assays on fresh field isolates are crucial to our
understanding of the dynamics of invasion in the natural context.
Previous studies examining alternative invasion pathways using
recently adapted or first-round invasion isolates have been con-
ducted in The Gambia, India, and Brazil [12–14]. This study was
initiated to determine the use of alternative invasion pathways
by a natural population of Tanzanian parasites, and to investi-
gate whether any correlation existed between specific pathways
and the differential expression of the PfRh and PfEBA ligands,
in order to determine the role that these ligands play in defining
invasion pathway utilization in vivo.
0166-6851/$ – see front matter © 2007 Elsevier B.V. All rights reserved.
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1. Variation in invasion pathway utilization
Invasion assays were performed as previously described [6]
to determine invasion efficiencies of Tanzanian isolates into
erythrocytes that had been treated with enzymes to expose alter-
native invasion pathways—neuraminidase removes sialic-acid
from erythrocyte receptors, while trypsin and chymotrypsin
cleave non-overlapping sets of protein receptors. Of the 89 total
invasion assays performed, 27 developed to schizonts in in vitro
culture. Of these 27, 11 P. falciparum isolates (41%) success-
fully reinvaded treated donor cells—a success rate comparable
to that observed in other field studies.
We observed significant variation in invasion pathway uti-
lization, measured as the percent invasion into enzyme-treated
erythrocytes compared to untreated controls (Table 1). A signifi-
cant association was observed in the use of trypsin-sensitive and
chymotrypsin-sensitive receptors between isolates (Rs = 0.70,
p= 0.017, Spearman’s) (Fig. 1C). We observed no association
between the use of these pathways and neuraminidase-sensitive
receptors (Fig. 1A and B).
Nested PCR amplifying MSP-1 and MSP-2 was performed to
determine parasite clonality [15]; all isolates were multiclonal
with a mean clonality of 3.5 parasite genotypes per patient.
2. Polarized expression of invasion ligands
To determine the extent of variant expression of PfRh and
PfEBA invasion ligands, we performed Western blots on para-
site proteins using polyclonal antibodies (Fig. 2A). Supernatants
have been shown to reflect the levels of invasion molecules
expressed in schizonts and are therefore useful in determining
protein expression and secretion during invasion [16] (data not
shown).
Importantly, we used two different schizont stage controls
to normalize loading volumes and expression levels: PfSERA5
and PfAMA-1. PfSERA5 is released during schizont rupture
and is unlikely to be functionally linked to the expression of the
PfRh and PfEBA proteins. PfAMA-1 is essential and is unlikely
to vary in expression level and is secreted during invasion in
a similar manner to PfRh and PfEBA proteins. The correlation
coefficients obtained when controlling with either PfSERA5 or
PfAMA-1 were virtually identical, legitimizing the use of these
proteins as controls to estimate the expression levels of PfRh and
PfEBA proteins (data not shown). PfAMA-1 expression values
were used in subsequent analysis to normalize expression.
Significant variation in the expression level of individual
PfRh and PfEBA proteins was observed (Fig. 2A), with clear
evidence of coordinate expression between some sets of lig-
ands (Fig. 2B). PfRh2a and PfRh2b expression, for example,
was tightly correlated (Rs = 0.94, p= 0.0001, Spearman’s), sug-
gesting coordinate expression of these proteins. In contrast,
expression of PfRh1 was inversely correlated with that of PfRh2a
and PfRh2b (Rs = −0.92, p= 0.0002, Spearman’s). A significant
positive correlation was observed between expression of EBA-
181 and PfRh2b (Rs = 0.98,p< 0.00001, Spearman’s). Similarly,
a significant positive correlation was observed between EBA-
140 and EBA-175 levels (Rs = 0.85, p= 0.002, Spearman’s). No
other correlations between the different invasion ligands were
significant.
The polarized expression that we observe between PfRh1
and PfRh2a/PfRh2b in multiclonal isolates, is similar to the
patterns observed in clonal laboratory isolates [16]. This can
be interpreted in two ways—firstly that there are dominant
clones within each isolate, which alternately express PfRh1
and PfRh2a/PfRh2b, and/or secondly that there are several
clones in each isolate, all which possess similar expression
Table 1
Invasion of red blood cells treated with neuraminidase, trypsin, and chymotrypsin by 11 Tanzanian P. falciparum field isolates
Sample Pre-assay: % parasitemiaa In vitro invasion assay: % parasitemia (± S.D.)b In vitro invasion assay: % invasionc
In patient Adjusted Control Nm-treated Trypsin-treated Chymo-treated Nm-treated Trypsin-treated Chymo-treated
MLD 013 1.60 0.80 1.20 ± 0.13 0.46 ± 0.085 0.11 ± 0.056 0.17 ± 0.00 38.46 9.23 13.85
MLD 018 2.10 1.05 2.30 ± 0.37 1.70 ± 0.032 0.29 ± 0.032 0.56 ± 0.15 73.90 12.85 24.10
MLD 019 1.70 0.85 1.03 ± 0.37 0.46 ± 0.085 0.33 ± 0.096 0.09 ± 0.032 44.64 32.14 8.93
MLD 021 2.00 1.00 1.13 ± 0.13 0.48 ± 0.085 0.20 ± 0.032 0.07 ± 0.032 42.62 18.03 6.56
MLD 022 1.30 0.65 0.57 ± 0.085 0.39 ± 0.056 0.15 ± 0.064 0.07 ± 0.032 67.74 25.81 12.90
MLD 052 7.50 1.00 0.48 ± 0.064 0.28 ± 0.056 0.46 ± 0.064 0.24 ± 0.032 57.69 96.15 50.00
MLD 054 1.80 0.90 1.09 ± 0.032 0.02 ± 0.056 0.57 ± 0.056 0.42 ± 0.064 13.43 58.21 43.28
MLD 056 4.20 1.00 0.48 ± 0.056 0.28 ± 0.056 0.31 ± 0.085 0.22 ± 0.00 57.69 61.54 46.15
MLD 080 1.70 0.85 0.60 ± 0.14 0.33 ± 0.056 0.43 ± 0.064 0.17 ± 0.00 55.38 70.77 27.69
MLD 081 1.80 0.90 0.99 ± 0.23 0.47 ± 0.032 0.19 ± 0.032 0.07 ± 0.032 46.30 18.52 7.41
MLD 082 1.00 0.50 0.65 ± 0.078 0.22 ± 0.056 0.33 ± 0.056 0.11 ± 0.00 34.48 51.72 17.24
Blood samples were collected from 100 patients with clinically mild malaria and no reported prior antimalarial treatment from the Mlandizi Health Centre in Tanzania
(January to June, 2004). if peripheral blood parasitemia exceeded 1.0%, following informed consent from patients and their guardians. Acceptor erythrocytes from a
single local O + donor were washed and treated with neuraminidase (66.7 mU/ml), trypsin (1 mg/ml) or chymotrypsin (1 mg/ml) for 1 hour at 37 ◦C. Positive control
cells were treated with RPMI and negative control cells with neuraminidase and chymotrypsin. Infected donor blood was adjusted to 1–2% parasitemia and treated
with neuraminidase and chymotrypsin to prevent reinvasion. Equal volumes of infected donor cells and treated acceptor cells were plated in triplicate in 96-well
plates resulting in a final parasitemia between 0.5–1 and 4% hematocrit. Plates were cultured in a candle jar at 37 ◦C for one invasion cycle. Successful reinvasion
was defined as greater than 0.5% parasitemia post-invasion. Percent invasion into enzyme-treated cells compared to control cells is shown for 11 isolates.
a Parasitemia is calculated as the number of parasitized red cells per 1800 uninfected red cells × 100.
b Standard deviation of invasion parasitemia is calculated between triplicate wells in the assay.
c Percent invasion is calculated as (parasitemia of enzyme-treated cells)/(parasitemia of control cells) × 100.
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Fig. 1. Variation in utilization of invasion pathways in Tanzanian field
isolates. (A–C) Correlations of invasion efficiencies into enzyme-treated ery-
throcytes for the series of isolates. Rs(p) and p-values shown are derived
from Spearman’s Rank Correlation. (A) Percent invasion into neuraminidase-
treated cells compared to chymotrypsin-treated cells. (B) Percent invasion into
neuraminidase-treated cells compared to trypsin-treated cells. (C) Percent inva-
sion into chymotrypsin-treated cells compared to trypsin-treated cells.
phenotypes, expressing either PfRh1 or PfRh2a/PfRh2b, with
polarized expression resulting from selection for parasites with
similar expression profiles in each isolate. The latter explana-
tion is consistent with the notion that invasion ligands such as the
PfRh and PfEBA are under frequency-dependent selection. Sim-
ilar correlations have been made with regards PfRh and PfEBA
transcript levels in multiclonal isolates from Kenya [17].
3. Correlation of PfRh and PfEBA protein expression
with invasion pathway utilization
We next determined whether correlations existed between
individual invasion pathways and variant expression of PfRh
and PfEBA proteins (Fig. 2C). Parasite populations in
which PfRh1 was highly expressed invaded in a trypsin-
resistant (Rs = 0.73, p= 0.016, Spearman’s), chymotrypsin-
resistant manner (Rs = 0.71, p= 0.022, Spearman’s). In
contrast, parasite populations in which PfRh2b was highly
expressed invaded in a trypsin-sensitive (Rs = −0.87, p= 0.0012,
Spearman’s), chymotrypsin-sensitive manner (Rs = −0.78,
p= 0.0075). Expression of PfRh2a and PfEBA-181 also strongly
correlated with the use of a trypsin- and chymotrypsin-sensitive
receptor (data not shown). No significant associations were evi-
dent between the expression level of any of the invasion ligands
and the use of sialic acid-containing receptors. There was no
correlation observed between the time post-schizont rupture at
which supernatant was collected and the expression profile of
any individual invasion ligand (for all comparisons, p> 0.23,
Spearman’s), ruling out variation in supernatant protein stability
as an explanation for our results.
4. Implications for our understanding of alternative
invasion pathways
In these studies, we have examined the extent to which
P. falciparum parasites isolated from individuals within a
single Tanzanian population utilize alternative pathways for
the erythrocyte invasion. Invasion assays were conducted
without culturing to avoid potential bias resulting from culture-
adaptation. We found considerable variation in the use of
alternative invasion pathways, in contrast to a previous study
in The Gambia in which most isolates utilized sialic acid-
independent and trypsin-sensitive receptors [13]. Isolates from
India and Brazil have demonstrated a greater reliance on trypsin-
resistant receptors [12,14]. The strong association between the
use of trypsin-sensitive and chymotrypsin-sensitive receptors
in some of our isolates (Fig. 1C) is suggestive of the use of a
common dominant receptor. In contrast, the lack of association
between the use of sialic acid-containing receptors and trypsin-
and chymotrypsin-sensitive receptors, suggests a more complex
relationship.
Our study represents the first analysis of protein expression
levels of multiple merozoite proteins from a series of fresh iso-
lates from a single population. We found considerable variation
in the expression levels of PfEBA and PfRh proteins. While
variation in PfRh protein expression is consistent with what we
and others have observed in laboratory isolates [5,6,16], the
dramatic degree of variant expression of PfEBA paralogs has
not previously been observed using laboratory-adapted strains.
This result highlights the importance of conducting these studies
using first-round invasion isolates from the field.
Despite our small sample size, there were significant cor-
relations in the expression levels of certain invasion ligands,
suggesting a strong molecular basis for these associations
(Fig. 2B). The positive correlation between PfRh2a and PfRh2b
is not surprising, as they share similar promoter sequences, lie
head to tail on chromosome 13, and are coordinately expressed
in laboratory isolates [6]. More intriguing are the associations
between the expression levels of PfRh2b and EBA-181, and
between EBA-175 and EBA-140, which may reflect the use
of shared mechanisms for coordinate expression. Interestingly,
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Fig. 2. Polarized expression of invasion ligands correlates with invasion pathway. (A) Expression profile of invasion ligands in the PfRh and PfEBA families. Parasite
protein was collected after short-term culture of infected blood treated with neuraminidase and chymotrypsin. Between 10 and 24 h following schizont rupture,
supernatant containing processed forms of secreted invasion ligands was collected and stored at −80 ◦C. Invasion supernatants were run on 5% SDS-PAGE gels
for maximum separation of PfRh and PfEBA proteins. Polyclonal antibodies against PfEBA-140, PfEBA-175, PfEBA-181, PfAMA-1, and PfSERA5 were kindly
provided by Prof. Alan Cowman and Dr. Brendan Crabb (WEHI, Australia). Antibodies against PfRh1, PfRh2a and PfRh2b have been described previously [3,4]. All
samples were controlled with PfAMA-1 and PfSERA-5. Quantification of bands corresponding to processed forms of invasion proteins [3,4,5–10] was performed using
UN-SCAN-ITTM software (Silk Scientific Inc., V. 5.1). (B) Quantitation reveals polarized expression of invasion ligands with positive correlations for Rh2a and Rh2b,
EBA181 and Rh2b, and EBA140 and EBA 175; and negative correlations for Rh1 and Rh2a/2b. (C) Correlation of expression profile with invasion pathway utilization.
Positive associations are observed between expression of Rh1 with trypsin-resistant, chymotrypsin-resistant invasion and expression of Rh2a/2b with trypsin-sensitive,
chymotrypsin-sensitive invasion. Rs(p) and p-values shown are derived from Spearman’s Rank Correlation. Expression is represented in arbitrary units.
both PfRh2b and EBA-181 are thought to bind chymotrypsin-
sensitive receptors [6,9,18] and it is possible that they may both
be present within a common invasion complex that engages the
same receptor. Significant correlations were observed between
PfRh2a and PfRh2b transcript levels in multiclonal Kenyan iso-
lates, with inverse correlations between PfRh1 and PfRh2b [17],
corroborating our findings. However, in contrast to our study, a
strong inverse correlation was observed between PfRh2b and
EBA-175. Future studies are required to determine whether this
reflects genuine differences between Kenyan and Tanzanian par-
asites or represents a lack of concordance between transcript and
protein levels for the merozoite proteins.
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This study, which used multiclonal isolates, reflects the real-
ity of P. falciparum infections in many areas of sub-Saharan
Africa. However, because of this multiclonality a caveat needs
to be raised. PfRh and PfEBA levels measured in culture super-
natants represent the total expression profiles for all of the clones
within an isolate, while only a subset of specific clones within
that pool actually successfully invade in the invasion assays. By
making associations between expression and invasion, we may
be comparing two different, albeit overlapping, groups of para-
sites. Comparing PfRh and PfEBA expression both before and
after invasion would be a powerful way to address this prob-
lem in future studies. Nevertheless, the correlations we have
observed are very similar to those found in previous studies
using laboratory-adapted isolates [4,6,16].
Reverse genetic studies previously implicated PfRh1 in bind-
ing a trypsin/chymotrypsin-resistant receptor termed Receptor Y
[16]. Increased PfRh1 expression in these Tanzanian isolates was
positively correlated with invasion by a trypsin/chymotrypsin-
resistant pathway. Interestingly, we found no association
between PfRh1 expression and neuraminidase-sensitivity, as
was previously observed in laboratory strains [16], sug-
gesting that additional ligands also contribute to sialic
acid-dependence. We previously found the receptor for PfRh2b
to be chymotrypsin-sensitive and trypsin-resistant [11]; how-
ever, here we report that the level of PfRh2b is correlated
with a chymotrypsin-sensitive, but trypsin-sensitive invasion
pathway. Interestingly, we have recently found that tar-
geted deletion of PfRh2b in the W2mef parasite line, which
expresses both PfRh2b and PfRh1, results in an increased
reliance on a chymotrypsin-resistant, trypsin-resistant inva-
sion pathway, consistent with our field data (Jennings et al.,
manuscript in preparation). Therefore, in the absence of PfRh2b
expression, parasites may become more reliant on the trypsin-
resistant and chymotrypsin-resistant PfRh1-associated invasion
pathway.
It is striking that we see such polarized expression of mero-
zoite proteins in the multiclonal Tanzanian isolates. These
expression patterns may represent frequency-dependent selec-
tion either by polymorphic host receptors or by immune
responses, supporting the consideration of these proteins as
vaccine candidates. While sequence polymorphisms have been
identified in PfRh and PfEBA genes that may influence inva-
sion pathways [3–5,19], their analysis in our study is precluded
due to the multiclonality of the isolates. Larger studies, focused
on the expression levels of the PfRh and PfEBA proteins and
the invasion pathways they define, may reveal a role in disease
severity and immune evasion.
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